D.E. Shaw & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $246K | Sell |
500
-6,100
| -92% | -$3.31M | ﹤0.01% | 4137 |
|
|
2025
Q4 | $3.82M | Sell |
6,600
-8,600
| -57% | -$4.86M | ﹤0.01% | 2534 |
|
|
2025
Q3 | $7.37M | Sell |
15,200
-44,400
| -74% | -$20.7M | ﹤0.01% | 1894 |
|
|
2025
Q2 | $24.2M | Buy |
59,600
+55,000
| +1,196% | +$23M | 0.02% | 922 |
|
|
2025
Q1 | $2.29M | Sell |
4,600
-4,400
| -49% | -$2.38M | ﹤0.01% | 2506 |
|
|
2024
Q4 | $4.68M | Buy |
+9,000
| New | +$4.95M | ﹤0.01% | 2034 |
|
|
2024
Q2 | – | Sell |
-12,700
| Closed | -$7.38M | – | 4844 |
|
|
2024
Q1 | $7.38M | Sell |
12,700
-25,400
| -67% | -$14.3M | 0.01% | 1598 |
|
|
2023
Q4 | $20.2M | Buy |
38,100
+26,900
| +240% | +$13M | 0.02% | 913 |
|
|
2023
Q3 | $5.67M | Buy |
11,200
+2,000
| +22% | +$1.07M | 0.01% | 1713 |
|
|
2023
Q2 | $4.8M | Sell |
9,200
-8,300
| -47% | -$4.48M | ﹤0.01% | 1882 |
|
|
2023
Q1 | $10.1M | Sell |
17,500
-45,600
| -72% | -$25.7M | 0.01% | 1360 |
|
|
2022
Q4 | $34.7M | Buy |
63,100
+14,100
| +29% | +$7.47M | 0.04% | 598 |
|
|
2022
Q3 | $24.9M | Sell |
49,000
-5,000
| -9% | -$2.8M | 0.03% | 723 |
|
|
2022
Q2 | $29.3M | Sell |
54,000
-25,500
| -32% | -$14M | 0.03% | 649 |
|
|
2022
Q1 | $47M | Buy |
79,500
+49,500
| +165% | +$28.4M | 0.04% | 515 |
|
|
2021
Q4 | $20M | Buy |
30,000
+20,000
| +200% | +$12.5M | 0.02% | 1087 |
|
|
2021
Q3 | $5.71M | Sell |
10,000
-3,200
| -24% | -$1.76M | 0.01% | 1982 |
|
|
2021
Q2 | $6.66M | Buy |
+13,200
| New | +$6.23M | 0.01% | 1810 |
|
|
2018
Q2 | – | Sell |
-2,200
| Closed | -$454K | – | 3896 |
|
|
2018
Q1 | $454K | Buy |
+2,200
| New | +$462K | ﹤0.01% | 2932 |
|
|
2017
Q2 | – | Sell |
-55,400
| Closed | -$8.51M | – | 3541 |
|
|
2017
Q1 | $8.51M | Hold |
55,400
| – | – | 0.02% | 972 |
|
|
2016
Q4 | $7.82M | Buy |
+55,400
| New | +$8.17M | 0.01% | 1089 |
|
|
2016
Q1 | – | Sell |
-134,700
| Closed | -$19.1M | – | 3773 |
|
|
2015
Q4 | $19.1M | Hold |
134,700
| – | – | 0.03% | 652 |
|
|
2015
Q3 | $16.5M | Hold |
134,700
| – | – | 0.02% | 697 |
|
|
2015
Q2 | $17.5M | Hold |
134,700
| – | – | 0.03% | 684 |
|
|
2015
Q1 | $18.1M | Sell |
134,700
-14,400
| -10% | -$1.86M | 0.03% | 636 |
|
|
2014
Q4 | $18.7M | Hold |
149,100
| – | – | 0.02% | 748 |
|
|
2014
Q3 | $18.1M | Hold |
149,100
| – | – | 0.02% | 750 |
|
|
2014
Q2 | $17.6M | Sell |
149,100
-23,900
| -14% | -$2.81M | 0.02% | 761 |
|
|
2014
Q1 | $20.8M | Buy |
173,000
+57,800
| +50% | +$6.87M | 0.03% | 631 |
|
|
2013
Q4 | $12.8M | Buy |
115,200
+68,800
| +148% | +$6.84M | 0.02% | 956 |
|
|
2013
Q3 | $4.28M | Buy |
46,400
+36,000
| +346% | +$3.26M | 0.01% | 1751 |
|
|
2013
Q2 | $880K | Buy |
+10,400
| New | +$866K | ﹤0.01% | 2825 |
|
Other funds holding TMO
VCM
D.E. Shaw & Co's TMO Position: Q1 2026 in Review
D.E. Shaw & Co increased its Thermo Fisher Scientific (TMO) stake by 537% in Q1 2026, buying an estimated $139M and bringing the position to 302,848 shares worth $149M. The position accounts for 0.09% of the portfolio, ranked #253.
D.E. Shaw & Co first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $538M in Q2 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- D.E. Shaw & Co held 302,848 shares of Thermo Fisher Scientific worth $149M as of Q1 2026.
- D.E. Shaw & Co bought 255,305 Thermo Fisher Scientific shares in Q1 2026, an estimated $139M.
- Thermo Fisher Scientific made up 0.09% of D.E. Shaw & Co's portfolio in Q1 2026, its #253 holding.
- D.E. Shaw & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- D.E. Shaw & Co's Thermo Fisher Scientific position peaked at $538M in Q2 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.